Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 3
1971 3
1973 1
1974 3
1975 1
1976 2
1980 2
1981 1
1984 1
1987 2
1988 1
1990 1
1992 1
1993 3
1995 2
1996 3
1997 2
1999 4
2000 4
2001 3
2002 4
2003 3
2004 7
2005 4
2006 4
2007 9
2008 5
2009 5
2010 13
2011 8
2012 13
2013 11
2014 11
2015 15
2016 14
2017 17
2018 14
2019 17
2020 25
2021 21
2022 15
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC, Piazuelo MB, Kuipers EJ, Li D. Shah SC, et al. Gastroenterology. 2021 Oct;161(4):1325-1332.e7. doi: 10.1053/j.gastro.2021.06.078. Epub 2021 Aug 26. Gastroenterology. 2021. PMID: 34454714 Free PMC article. Review.
Patients with a new diagnosis of pernicious anemia who have not had a recent endoscopy should undergo endoscopy with topographical biopsies to confirm corpus-predominant atrophic gastritis for risk stratification and to rule out prevalent gastric neoplasia, including neuroendo …
Patients with a new diagnosis of pernicious anemia who have not had a recent endoscopy should undergo endoscopy with topographical biopsies …
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.
Scott AT, Howe JR. Scott AT, et al. Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27. Surg Clin North Am. 2019. PMID: 31255207 Free PMC article. Review.
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. ...This review provides a concise summary of the presentation, diagnosis, surgical management, and systemic treatment of pancreatic neuroendocrine tumor …
Pancreatic neuroendocrine tumors are a diverse group of neoplasms with a generally favorable prognosis. ...This review provide …
Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Ma ZY, et al. World J Gastroenterol. 2020 May 21;26(19):2305-2322. doi: 10.3748/wjg.v26.i19.2305. World J Gastroenterol. 2020. PMID: 32476795 Free PMC article. Review.
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with complicated treatment options that depend on pathological grading, clinical staging, and presence of symptoms related to hormonal secretion. ...Great progress has been achieved …
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with complicated treatment options that de …
Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Deprez PH, Moons LMG, OʼToole D, Gincul R, Seicean A, Pimentel-Nunes P, Fernández-Esparrach G, Polkowski M, Vieth M, Borbath I, Moreels TG, Nieveen van Dijkum E, Blay JY, van Hooft JE. Deprez PH, et al. Endoscopy. 2022 Apr;54(4):412-429. doi: 10.1055/a-1751-5742. Epub 2022 Feb 18. Endoscopy. 2022. PMID: 35180797 Free article.
1: ESGE recommends endoscopic ultrasonography (EUS) as the best tool to characterize subepithelial lesion (SEL) features (size, location, originating layer, echogenicity, shape), but EUS alone is not able to distinguish among all types of SEL.Strong recommendation, moderate quali …
1: ESGE recommends endoscopic ultrasonography (EUS) as the best tool to characterize subepithelial lesion (SEL) features (size, location, or …
Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
Gonzalez RS. Gonzalez RS. Surg Pathol Clin. 2020 Sep;13(3):377-397. doi: 10.1016/j.path.2020.04.002. Surg Pathol Clin. 2020. PMID: 32773190 Review.
The latest WHO classification cleanly divides gastrointestinal neuroendocrine neoplasms into neuroendocrine tumor (NET; well-differentiated, any grade) and neuroendocrine carcinoma (NEC; poorly differentiated, high-grade by definition), along with mixed ne …
The latest WHO classification cleanly divides gastrointestinal neuroendocrine neoplasms into neuroendocrine tumor (NET; well-d …
Management of immune-related adverse events and kinetics of response with ipilimumab.
Weber JS, Kähler KC, Hauschild A. Weber JS, et al. J Clin Oncol. 2012 Jul 20;30(21):2691-7. doi: 10.1200/JCO.2012.41.6750. Epub 2012 May 21. J Clin Oncol. 2012. PMID: 22614989 Review.
We provide a detailed description of irAEs and recommendations for practicing oncologists who are managing them, along with the unusual kinetics of response associated with ipilimumab therapy....
We provide a detailed description of irAEs and recommendations for practicing oncologists who are managing them, along with the unusual kine …
Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.
Paniccia A, Polanco PM, Boone BA, Wald AI, McGrath K, Brand RE, Khalid A, Kubiliun N, O'Broin-Lennon AM, Park WG, Klapman J, Tharian B, Inamdar S, Fasanella K, Nasr J, Chennat J, Das R, DeWitt J, Easler JJ, Bick B, Singh H, Fairley KJ, Sarkaria S, Sawas T, Skef W, Slivka A, Tavakkoli A, Thakkar S, Kim V, Vanderveldt HD, Richardson A, Wallace MB, Brahmbhatt B, Engels M, Gabbert C, Dugum M, El-Dika S, Bhat Y, Ramrakhiani S, Bakis G, Rolshud D, Millspaugh G, Tielleman T, Schmidt C, Mansour J, Marsh W, Ongchin M, Centeno B, Monaco SE, Ohori NP, Lajara S, Thompson ED, Hruban RH, Bell PD, Smith K, Permuth JB, Vandenbussche C, Ernst W, Grupillo M, Kaya C, Hogg M, He J, Wolfgang CL, Lee KK, Zeh H, Zureikat A, Nikiforova MN, Singhi AD. Paniccia A, et al. Gastroenterology. 2023 Jan;164(1):117-133.e7. doi: 10.1053/j.gastro.2022.09.028. Epub 2022 Oct 6. Gastroenterology. 2023. PMID: 36209796 Free PMC article.
The sensitivities and specificities of VHL and MEN1/loss of heterozygosity alterations were 71% and 100% for serous cystadenomas (PPV, 100%; NPV, 98%), and 68% and 98% for pancreatic neuroendocrine tumors (PPV, 85%; NPV, 95%), respectively. On follow-up, serous cyst …
The sensitivities and specificities of VHL and MEN1/loss of heterozygosity alterations were 71% and 100% for serous cystadenomas (PPV, 100%; …
Updates in the diagnosis and management of small-bowel tumors.
Vlachou E, Koffas A, Toumpanakis C, Keuchel M. Vlachou E, et al. Best Pract Res Clin Gastroenterol. 2023 Jun-Aug;64-65:101860. doi: 10.1016/j.bpg.2023.101860. Epub 2023 Aug 12. Best Pract Res Clin Gastroenterol. 2023. PMID: 37652650 Review.
They are a heterogenous group of neoplasms comprising of about forty different histological subtypes with the most common being adenocarcinoma, neuroendocrine tumors, stromal tumors and lymphomas. Their incidence has been reportedly increasing over recent yea …
They are a heterogenous group of neoplasms comprising of about forty different histological subtypes with the most common being adenocarcino …
Management of Small Bowel Neuroendocrine Tumors.
Scott AT, Howe JR. Scott AT, et al. Surg Oncol Clin N Am. 2020 Apr;29(2):223-241. doi: 10.1016/j.soc.2019.11.006. Surg Oncol Clin N Am. 2020. PMID: 32151357 Review.
Small bowel neuroendocrine tumors (SBNETS) are slow-growing neoplasms with a noted propensity toward metastasis and comparatively favorable prognosis. ...The treatment of SBNETs is multimodal and includes surgery, liver-directed therapy, somatostatin analogue …
Small bowel neuroendocrine tumors (SBNETS) are slow-growing neoplasms with a noted propensity toward metastasis and comparativ …
Management of Small Bowel Neuroendocrine Tumors.
Scott AT, Howe JR. Scott AT, et al. J Oncol Pract. 2018 Aug;14(8):471-482. doi: 10.1200/JOP.18.00135. J Oncol Pract. 2018. PMID: 30096273 Free PMC article. Review.
Small bowel neuroendocrine tumors (NETs) are increasing in incidence and are now the most common primary malignancies of the small intestine. Despite this increase, the vague presentation and slow growth of these tumors lead to long delays in diagnosis, and m …
Small bowel neuroendocrine tumors (NETs) are increasing in incidence and are now the most common primary malignancies of the s …
260 results